July 31, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
ZOLL Medical Sets Up Japan Subsidiary
 

Tokyo, Oct 26, 2012 (JCN) - Asahi Kasei's wholly owned US subsidiary ZOLL Medical Corporation (ZOLL) has established Asahi Kasei ZOLL Medical Corporation - its Japanese subsidiary. Asahi Kasei ZOLL Medical, which will commence operations on 5 November 2012, will advance the expansion and development of ZOLL's business in Japan.

ZOLL, a leading US manufacturer of critical care devices and systems, was acquired by Asahi Kasei in line with its target to grow in the critical care segment. As a member company of the Asahi Kasei Group, ZOLL is accelerating the expansion of operations beyond the US and Europe, with a focus on Japan and other major Asian markets.

To further expand its Japanese business, ZOLL is working to obtain regulatory approval as quickly as possible for products currently sold in the US and Europe, while reinforcing its sales infrastructure in the country. Asahi Kasei ZOLL Medical will leverage the resources of the Asahi Kasei Group to facilitate these developments for the swift expansion of ZOLL's business in Japan.

In close collaboration with Admis, Asahi Kasei ZOLL Medical will work to increase sales of the ZOLL AED Plus while advancing preparations for the sale of other approved products such as Thermogard temperature management systems and ZOLL AED Pro automated external defibrillators for use by professional rescuers.

Application has been filed for Japanese regulatory approval of X Series monitor defibrillators and the LifeVest wearable defibrillator.

By Chris Lui Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Asahi Kasei Group News  
  Asahi Kasei Develops New Transparent Polymer for Optical Applications  (July 2, 2014)
  Asahi Kasei Chemicals to Manufacture Polyamide 66 Compounds in Indonesia  (Aug 8, 2013)
  Asahi Kasei Establishes Base in India  (Feb 25, 2013)
  Asahi Kasei Chemicals Opens AN and MMA Plants in Thailand  (Feb 14, 2013)
  Asahi Kasei Completes Construction of Kawasaki Innovation Center  (Dec 3, 2012)
  ZOLL Medical Sets Up Japan Subsidiary  (Oct 26, 2012)
  Asahi Kasei Microdevices Launches New 3-axis Electronic Compass for Mobile Devices  (July 23, 2012)
  Asahi Kasei Medical Takes Equity Stake in NxStage Medical  (May 10, 2012)
  Asahi Kasei Commences Tender Offer for ZOLL  (Mar 29, 2012)
  Asahi Kasei to Acquire ZOLL Medical  (Mar 14, 2012)



 Recent  Biotech News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Biotech news...

 Recent  Drugs & OTC News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Drugs & OTC news...

 Recent  Medical News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)